The significance of blockbusters in the pharmaceutical industry
Author: | Alexander SchuhmacherORCiD, Markus Hinder, Nikolaj Boger, Dominik Hartl, Oliver Gassmann |
---|---|
Language: | English |
Document Type: | Article |
Year of first Publication: | 2022 |
published in (English): | Nature Reviews Drug Discovery |
Publisher: | Springer Nature |
Place of publication: | London |
ISSN: | 1474-1784 |
Volume: | 22 |
Issue: | 3 |
First Page: | 177 |
Last Page: | 178 |
Review: | editorial review |
Open Access: | nein |
Version: | published |
Related Identifier: | https://doi.org/10.1038/d41573-022-00213-z |
Supplement: | https://www.nature.com/magazine-assets/d41573-022-00213-z/23814366 |
Supplement: | https://www.nature.com/magazine-assets/d41573-022-00213-z/23814364 |
Faculties / Institutes / Organizations: | THI Business School |
Release Date: | 2024/01/17 |